For the Inventor, By the Inventor

Enter assignee name

Abingdon, United Kingdom

Psioxus Therapeutics Limited

USPTO Granted Patents = 22

CIPO Patents = 22

EPO Patents = 8

Trademarks = 3

Forward Citations = 67

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Brian Robert Champion (10 out of 23 patents)

Alice Claire Noel Brown (8 out of 10 patents)

Terry Hermiston (7 out of 30 patents)

4. Irene Kuhn (6 out of 7 patents)

5. Paul Harden (5 out of 6 patents)

6. Kerry David Fisher (4 out of 9 patents)

7. Alice Claire Noel Bromley (3 out of 6 patents)

8. Tamara Nicolson (3 out of 7 patents)

9. John William Beadle (2 out of 2 patents)

10. Stefan Anker (1 out of 16 patents)

11. Christine Wilkinson Blanc (1 out of 2 patents)

12. Matthieu Besneux (1 out of 1 patent)

13. Jochen Springer (1 out of 9 patents)

14. Benjamin Guy Davis (1 out of 11 patents)

15. Peter Kretschmer (1 out of 4 patents)

22 patents: Sort by Forward Citations

1. 11439678 - Oncolytic adenoviruses armed with heterologous genes (2022-09-13),

2. 11173186 - Dosing regime and formulations for type B adenovirus (2021-11-16),

3. 11155622 - Virus encoding an anti-TCR-complex antibody or fragment (2021-10-26),

4. 11142580 - Oncolytic virus and method (2021-10-12),

5. 11000559 - Oncolytic adenovirus encoding a B7 protein (2021-05-11),

6. 10849945 - Oncolytic adenovirus encoding a B7 protein or active fragment (2020-12-01),

7. 10548929 - Oncolytic adenovirus encoding a therapeutic protein or active fragment (2020-02-04),

8. 10472648 - Method of making adenovirus and corresponding plasmids (2019-11-12),

9. 10322152 - Oncolytic adenovirus encoding a B7 protein (2019-06-18),

10. 10124028 - Oncolytic adenovirus encoding a B7 protein or active fragment (2018-11-13),

11. 10034905 - Group B adenovirus modified in the E4orf4 region (2018-07-31),

12. 9987314 - Oncolytic adenoviruses armed with heterologous genes (2018-06-05),

13. 9234185 - Chimeric adenoviruses for use in cancer treatment (2016-01-12),

14. 9115337 - Chimeric adenoviruses for use in cancer treatment (2015-08-25),

15. 9034344 - Chimeric adenoviruses for use in cancer treatment (2015-05-19),

PsiOxus Therapeutics Ltd. is a development stage biotechnology company specializing in the development of innovative immune-oncology medicines for the treatment of solid tumors. By using its proprietary oncolytic virus platform, ColoAd1, the company aims to develop safe and effective cancer treatments that can be used either alone or in combination with existing therapies. PsiOxus Therapeutics is committed to transforming the lives of cancer patients through the advancement of cutting-edge immunotherapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

22 Patents

#10 in Abingdon

#799 in United Kingdom

#27,863 in the World

Abingdon, United Kingdom

Psioxus Therapeutics Limited

Forward Citations = 67

27 inventors:

Brian Robert Champion (10 out of 23 patents)

Alice Claire Noel Brown (8 out of 10 patents)

Terry Hermiston (7 out of 30 patents)

4. Irene Kuhn (6 out of 7 patents)

5. Paul Harden (5 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…